ICON Public Limited Company Stock price

Equities

ICLR

IE0005711209

Biotechnology & Medical Research

Market Closed - Nasdaq 04:00:00 2024-03-01 pm EST 5-day change 1st Jan Change
325.5 USD +1.53% Intraday chart for ICON Public Limited Company +3.60% +14.99%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Enjoy this offer
* See conditions on site
Sales 2024 * 8.63B Sales 2025 * 9.27B Capitalization 26.85B
Net income 2024 * 821M Net income 2025 * 1.01B EV / Sales 2024 * 3.38 x
Net Debt 2024 * 2.34B Net Debt 2025 * 1.15B EV / Sales 2025 * 3.02 x
P/E ratio 2024 *
34 x
P/E ratio 2025 *
27.4 x
Employees 41,100
Yield 2024 *
-
Yield 2025 *
-
Free-Float 99.08%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.53%
1 week+3.60%
Current month+1.53%
1 month+24.96%
3 months+20.85%
6 months+23.91%
Current year+14.99%
More quotes
1 week
312.43
Extreme 312.43
326.03
1 month
256.96
Extreme 256.96
326.03
Current year
244.59
Extreme 244.59
326.03
1 year
181.92
Extreme 181.92
326.03
3 years
169.00
Extreme 168.995
326.03
5 years
104.28
Extreme 104.275
326.03
10 years
35.33
Extreme 35.33
326.03
More quotes
Managers TitleAgeSince
Chief Executive Officer 63 11-10-31
Director of Finance/CFO 45 05-12-31
Chairman 61 05-10-02
Members of the board TitleAgeSince
Founder 71 90-05-31
Chief Executive Officer 63 11-10-31
Director/Board Member 68 17-12-31
More insiders
Date Price Change Volume
24-03-01 325.5 +1.53% 450,738
24-02-29 320.6 -0.87% 478,537
24-02-28 323.4 +0.30% 508,457
24-02-27 322.5 +1.17% 514,029
24-02-26 318.7 +1.44% 891,728

Delayed Quote Nasdaq, March 01, 2024 at 04:00 pm EST

More quotes
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors. Its sectors include Biosimilars, Biotech, Government and public health solutions, medical devices, pharmaceuticals and the IVDR journey.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
325.5 USD
Average target price
350.6 USD
Spread / Average Target
+7.70%
Consensus
  1. Stock
  2. Equities
  3. Stock ICON Public Limited Company - Nasdaq
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW